Published: 2019-10-24

Microvascular complications and their prevalence in newly diagnosed type-2 diabetes mellitus

Angli Manhas, Meenakshi Gupta, Rameshwar S. Manhas, Dinesh Gupta, Gaurav S. Manhas


Background: A group of metabolic diseases is ‘diabetes’ which has become a major global concern is characterized by high blood sugar. In the world about 347 million people have diabetes. Untreated long standing hyperglycemia leads to microvascular complications in newly diagnosed DM. The objective of the study was to find out prevalence of microvascular complications in newly diagnosed Type-2 diabetes mellitus.

Methods: The present cross-sectional study was conducted over a period of 6 months involved 200 patients who were diagnosed with T2DM having ≤6 months duration was conducted in the out-patient department of medicine and ophthalmology at a tertiary care hospital. Informed consent was taken from all the participants who were willing to participate. Detailed history, clinical examination and relevant investigations were done to diagnose microvascular complications.

Results: Maximum number of studied subjects i.e. 54% were seen in age group of 41-50 yrs. Males were 56% whereas females comprised 44%. Total of 52% of subjects were from rural background. Nephropathy was the most common microvascular complication present in 54% patients followed by neuropathy in 30% and retinopathy in 8% (NPDR in 7% and PDR in 1%) of patients.

Conclusions: From the present study it has been concluded that nephropathy is the most common microvascular complication in newly diagnosed T2DM followed by neuropathy and retinopathy. Authors recommend that education of high-risk group regarding diabetes and its complications by electronic and print media is required so that they seek medical consultation at the earliest. Screening for diabetes at a younger age in view of lower average age at presentation and high prevalence of microvascular complications.


Diabetes mellitus, Nephropathy, Neuropathy, Retinopathy

Full Text:



Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Resea Clini Practice. 2014 Feb 1;103(2):137-49.

Shrikanth S, Susmitha A. Comparison of intraocular pressure and body mass index in diabetic and non-diabetic individual. Ind J Basic Appl Med Resea. 2013;2(8):939-45.

Mohan V, Deepa R. Adipocytokines and the expanding 'Asian Indian Phenotype'. J Assoc Physicians Ind. 2006 Sep 1;54:685-6.

Jani CT, Desai TR, Parikh S, Shah AS. Correlation of types of diabetic retinopathy and its psychosocial impact. Int J Res Med Sci. 2018;6:3220-5.

Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes care. 2006 Dec 1;29(12):27017.

Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes care. 1992 Jul 1;15(7):815-9.

Singh K, Shrivastava AK, Chandrakar N. Effect of Type II Diabetes mellitus on Intra ocular pressure in Central India. Ind J Clini Experimental Ophthalmol. 2017;3(1):28-30.

Al-Zamil WM. Hospital prevalence of retinopathy in patients with newly-diagnosed type 2 diabetes. Saudi J Med Medical Sci. 2017 Jan;5(1):26-30.

Margolis S. Diabetic microvascular complications: An overview. Adv Stud Med. 2005;5:S260-3.

Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmol. 1991 May 1;98(5):786-806.

Sosale A, Kumar PKM, Sadikot SM, Nigam A, Bajaj S, Zargar AH, et al. Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India. Ind J Endocrinol Metab. 2014;18:355-60.

Anandalakshmi S, Petrecia H. Intaocular pressure in subjects with type diabetes mellitus. J Clini Diagnostic Resea. 2011;Vol-5(7):1336-8.

Wani FA, Kaul R, Raina AA, Nazir A, Maqbool M, Bhat MH, et al. Prevalence of microvascular complications in newly diagnosed type-2 diabetes mellitus. Int J Sci Stud. 2016 Jan 1;3(10):102-5.

Ali A, Iqbal F, Taj A, Iqbal Z, Amin MJ, Iqbal QZ. Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes. Pak J Medical Sci. 2013 Jul;29(4):899-902.

Yash P, Shingare A, Kalita G, Bhandari V. A clinical study if microvascular complications in newly diagnosed diabetes mellitus patients. Indian J Appl Res. 2014;4:12-4.

Nambuya AP, Otim MA, Whitehead H, Mulvany D, Kennedy R, Hadden DR. The presentation of newly-diagnosed diabetic patients in Uganda. QJM: An Internat J Med. 1996 Sep 1;89(9):705-12.

Karmakar RN, Khandakar MR, Gangopadhyay PK, Ghosh K, Babu AS. Albuminuria and neuropathy in newly detected diabetics: profile and correlation. J Ind Medical Assoc. 2011 Jun;109(6):396-9.

Engelgau MM, Aubert RE, Thompson TJ, Herman WH. Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations. Diabetes care. 1995 Dec;18(12):1606-18.

Cathelineau G, de Champvallins M, Bouallouche A, Lesobre B. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment-the Diadem Study. Metabolism-Clini Experimental. 1997 Dec 1;46:31-4.

Xu Z, Wang Y, Wang X. Chronic diabetic complications and treatments in Chinese diabetic patients. Zhonghua Yi Xue Za Zhi. 1997 Feb;77(2):119-22.